TOFT better explains experimental results in cancer research than SMT (Comment on DOI 10.1002/bies.201100025 and DOI 10.1002/bies.201100022)

BioEssays

Volumn 33, Issue 12, 2011, Pages 919-921

  Baker, Stuart G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BCR ABL PROTEIN; CARCINOGEN; HYBRID PROTEIN; K RAS PROTEIN;

BREAST EPITHELIUM; CANCER GROWTH; CANCER RESEARCH; CARCINOGENESIS; CHROMOSOMAL INSTABILITY; CHROMOSOME TRANSLOCATION; EPITHELIUM CELL; GENE MUTATION; HUMAN; INTRACELLULAR SIGNALING; MELANOMA CELL; NONHUMAN; NOTE; ONCOGENE; ONCOGENE K RAS; PHAGOCYTOSIS; SOMATIC MUTATION THEORY; STROMA; TISSUE ORGANIZATION FIELD THEORY; TRANSGENIC MOUSE; TUMOR REGRESSION;

ANIMALS; HUMANS; MUTATION; NEOPLASMS;

EID: 81355148564     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201100124     Document Type: Note

References (17)

1. Soto AM, Sonnenschein C. 2011. The tissue organization field theory of cancer: a testable replacement for the somatic mutation theory. BioEssays 33: 332- 40.
2. Vaux DL. 2011. In defense of the somatic mutation theory of cancer. BioEssays 33: 341- 3.
3. Chamberlin C. 1965. The method of multiple working hypotheses. Science 148: 754- 9.
4. Dong J, Phelps RG, Qiao R, Yao S, et al. 2003. BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma. Cancer Res 63: 3883- 5.
5. Podsypanina K, Politi K, Beverly LJ, Varmus HE. 2008. Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant Kras. Proc Natl Acad Sci USA 105: 5242- 7.
6. Booth BW, Boulanger CA, Anderson LH, Smith GH. 2011. The normal mammary microenvironment suppresses the tumorigenic phenotype of mouse mammary tumor virus-neu-transformed mammary tumor cells. Oncogene 30: 679- 89.
7. Kantarjian H, Sawyers C, Hochhaus A, Guilhot F, et al. 2002. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 346: 645- 52.
8. Bischoff F, Bryson G. 1964. Carcinogenesis through solid state surfaces. Prog Exp Tumor Exp Tumor Res 14: 85- 133.
9. Karp RD, Johnson KH, Buoen LC, Ghobrial HKG, et al. 1973. Tumorigenesis by Millipore filters in mice: histology and ultrastructure of tissue reactions as related to pore size. J Natl Cancer Inst 51: 1275- 85.
10. Baker SG, Kramer BS. 2007. Paradoxes in carcinogenesis: new opportunities for research directions. BMC Cancer 7: 151.
11. Maffini MV, Soto AM, Calabro JM, Ucci AA, et al. 2004. The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci 117: 1495- 502.
12. Bissell MJ, Hines WC. 2011. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 17: 320- 9.
13. Raaijmakers MH, Mukherjee S, Guo S, Zhang S, et al. 2010. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 464: 852- 7.
14. Yoko K, Roger L, Gaizka O. 2010. RNAase-III enzyme Dicer maintains signaling pathways for differentiation and survival in mouse cortical neural stem cells. J Cell Sci 123: 586- 94.
15. Baker SG, Cappuccio A, Potter JD. 2010. Research on early-stage carcinogenesis: are we approaching paradigm instability? J Clin Oncol 28: 3215- 8.
16. Dyson F. 2007. Heretical thoughts about science and society. Edge 219.
17. Heschel AJ, Heschel S, Neugroschel J. 1981. Maimonides: A Biography. Toronto: McGraw-Hill Ryerson.